Thermo Fisher Scientific (TMO) Depreciation & Amortization (CF) (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Depreciation & Amortization (CF) for 18 consecutive years, with $306.0 million the latest figure, recorded in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $306.0 million, up 10.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 5.75% YoY), and the FY2025 annual result was $1.0 billion, down 9.17% from the prior year.
• Depreciation & Amortization (CF) was $306.0 million for Q1 2026 at Thermo Fisher Scientific, up from $292.0 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $306.0 million in Q1 2026 and troughed at $227.0 million in Q3 2025.
• Average Depreciation & Amortization (CF) over 5 years is $268.6 million, with a median of $270.0 million recorded in 2023.
• Year-over-year, Depreciation & Amortization (CF) climbed 26.26% in 2022 and retreated 21.99% in 2025.
• Over 5 years, Depreciation & Amortization (CF) stood at $256.0 million in 2022, then increased by 7.81% to $276.0 million in 2023, then increased by 10.14% to $304.0 million in 2024, then retreated by 3.95% to $292.0 million in 2025, then increased by 4.79% to $306.0 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $306.0 million in Q1 2026, $292.0 million in Q4 2025, and $227.0 million in Q3 2025.